Market Tracker

05/27 6:02pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

239.12
Delayed Data
As of May 27
 +3.81 / +1.62%
Today’s Change
106.00
Today|||52-Week Range
239.16
+67.09%
Year-to-Date

Today’s Trading

Previous close235.31
Today’s open236.00
Day’s range234.56 - 239.16
Volume2,389,990
Average volume (3 months)2,370,416
Market cap$80.2B
Dividend yield--
Data as of 4:01pm ET, 05/27/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+32.91%
Earnings growth (next 5 years)+26.30%
Revenue growth (last year)+43.22%
P/E ratio89.4
Price/Sales5.83
Price/Book14.81

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.59+0.79%
AZNAstraZeneca+1.07+1.58%
ABTAbbott Laboratories+0.41+0.84%
CELGCelgene+1.56+1.36%
Data as of 4:03pm ET, 05/27/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)$2.44
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts